Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


From Ideas to Opportunities: Social Enterprise

Publication date: Oct 25, 2012 10:09 AM

Start: Nov 19, 2012 05:30 PM
End: Nov 19, 2012 07:30 PM

Location: UCL

UCLB

UCLB invites you to a unique event that will feature a diversity of perspectives on social enterprise including established social ventures, funding organisations that support innovative social entrepreneurs, as well as initiatives from UCL academic staff.

Do not miss this opportunity to learn more about:

  • Turning your idea into a product or service that can create positive social impact in society
  • Funding opportunities for social enterprise
  • The challenges for academic entrepreneurs
  • How UCL Business can help you

Guest speakers include:

  • Katie Hill, Social Investment Advisor, City of London Corporation
  • Prof Muki Haklay, Professor of Geographic Information Science at UCL and co-founder of Mapping for Change
  • Dr Mohammad Al-Ubaydli, CEO, Patients Know Best
  • Kieron Kirkland, Development Researcher, Nominet Trust

Click here to register for 'From Ideas to Opportunities: Social Enterprise and Social Investment'